Literature DB >> 12567296

Respiratory tract infections in travelers: a review of the GeoSentinel surveillance network.

Karin Leder1, Vijaya Sundararajan, Leisa Weld, Prativa Pandey, Graham Brown, Joseph Torresi.   

Abstract

Respiratory tract infections are common in travelers, and improving our knowledge of risk factors associated with specific types of respiratory infections should enable implementation of better preventive strategies. Data collected by the GeoSentinel surveillance network were analyzed, and the most significant predictors for developing specific categories of respiratory infections while abroad were age, sex, season of travel, trip duration, and reason for travel. In particular, influenza was associated with travel to the Northern Hemisphere during the period of December through February, travel involving visits to friends or relatives, and trip duration of >30 days. Lower respiratory tract infections were associated with male sex and increasing age. Knowledge of the respiratory tract infections that occur in specific groups of travelers allows for the development of targeted pretravel preventive strategies to high-risk groups.

Entities:  

Mesh:

Year:  2003        PMID: 12567296     DOI: 10.1086/346155

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Health risks and travel preparation among foreign visitors and expatriates during the 2008 Beijing Olympic and Paralympic Games.

Authors:  Emily S Jentes; Xiaohong M Davis; Susan Macdonald; P Johann Snyman; Hugh Nelson; Doug Quarry; Irene Lai; Erik W N van Vliet; Victor Balaban; Cinzia Marano; Katherine Mues; Phyllis Kozarsky; Nina Marano
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

2.  STATEMENT ON PEDIATRIC TRAVELLERS: Committee to Advise on Tropical Medicine and Travel.

Authors:  S Kuhn; C Hui
Journal:  Can Commun Dis Rep       Date:  2010-06-10

3.  Effect of Omicron on the prevalence of COVID-19 in international travelers at the Mexico city international airport. December 16th, 2021 to January 31st, 2022.

Authors:  Gustavo Olaiz-Fernández; Félix Jesús Vicuña de Anda; Jorge-Baruch Diaz-Ramirez; German E Fajardo Dolci; Patricia Bautista-Carbajal; Antonio Humberto Angel-Ambrocio; Miguel Leonardo García-León; Elena Gómez Peña; Jorge Alejandro Camacho Morales; Rosa Maria Wong-Chew
Journal:  Travel Med Infect Dis       Date:  2022-05-29       Impact factor: 20.441

4.  Imported infectious disease and purpose of travel, Switzerland.

Authors:  Lukas Fenner; Rainer Weber; Robert Steffen; Patricia Schlagenhauf
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

5.  Prevention of influenza among travellers attending at a UK travel clinic: beliefs and perceptions. A cross-sectional study.

Authors:  Cristina Masuet-Aumatell; Stephen Toovey; Jane N Zuckerman
Journal:  Influenza Other Respir Viruses       Date:  2012-09-24       Impact factor: 4.380

Review 6.  Pulmonary infections in the returned traveller.

Authors:  Ashleigh Trimble; V Moffat; A M Collins
Journal:  Pneumonia (Nathan)       Date:  2017-01-25

Review 7.  Respiratory infections in travelers returning from the tropics.

Authors:  Krzysztof Korzeniewski; Aneta Nitsch-Osuch; Anna Lass; Aneta Guzek
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

8.  Fever in travelers returning from tropical areas: prospective observational study of 613 cases hospitalised in Marseilles, France, 1999-2003.

Authors:  Philippe Parola; Georges Soula; Pierre Gazin; Cedric Foucault; Jean Delmont; Philippe Brouqui
Journal:  Travel Med Infect Dis       Date:  2006-03       Impact factor: 6.211

9.  Combining clinical and epidemiologic features for early recognition of SARS.

Authors:  John A Jernigan; Donald E Low; Rita F Hefland
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

10.  Effect of travel on influenza epidemiology.

Authors:  Sanne-Meike Belderok; Guus F Rimmelzwaan; Anneke van den Hoek; Gerard J B Sonder
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.